WallStreetZenWallStreetZen

NASDAQ: ALLR
Allarity Therapeutics Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

ALLR past revenue growth

How has ALLR's revenue growth performed historically?
Company
N/A
Industry
172.23%
Market
17.3%
ALLR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ALLR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ALLR earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$20.4M
Current Profit Margin
0%

ALLR Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when ALLR announces earnings.

ALLR Return on Assets

Current Company
-157.5%
Current Industry
2.9%
ALLR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALLR Return on Capital Employed

Current Company
491.11%
Current Industry
19.5%
ALLR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALLR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALLR$0.00-$11.28M-$20.42M-100.00%N/A
APVO$0.00-$16.84M-$17.41M-100.00%N/A
SPRC$767.73k$1.80M$1.37M+108.44%N/A
GRI$0.00-$10.95M-$13.04M-100.00%N/A
VRAX$79.30kN/A-$6.92M-15.02%N/A
View Top Biotech Stocks

Allarity Therapeutics Earnings & Revenue FAQ

What were ALLR's earnings last quarter?

Allarity Therapeutics (NASDAQ: ALLR) reported Q4 2023 earnings per share (EPS) of $182.40, up 102.53% year over year. Total Allarity Therapeutics earnings for the quarter were -$1.72 million. In the same quarter last year, Allarity Therapeutics's earnings per share (EPS) was -$7,204.20.

If you're new to stock investing, here's how to buy Allarity Therapeutics stock.

What was ALLR's earnings growth in the past year?

As of Q2 2024, Allarity Therapeutics's earnings has grown year over year. Allarity Therapeutics's earnings in the past year totalled -$20.42 million.

What was ALLR's revenue last quarter?

Allarity Therapeutics (NASDAQ: ALLR) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Allarity Therapeutics's revenue was $0.00.

What was ALLR's revenue growth in the past year?

As of Q2 2024, Allarity Therapeutics's revenue has grown null year over year. Allarity Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.